Gladsaxe Smed A/S

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  15.4% 12.0% 11.4% 14.8% 4.6%  
Credit score (0-100)  14 20 20 13 45  
Credit rating  BB BB BB BB BBB  
Credit limit (kDKK)  -0.0 -0.0 -0.0 -0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9

Net sales  0 0 0 0 0  
Gross profit  304 698 580 877 517  
EBITDA  -122 270 38.2 20.2 258  
EBIT  -122 270 38.2 20.2 258  
Pre-tax profit (PTP)  -296.0 -95.4 -337.0 -360.8 258.7  
Net earnings  82.4 -69.4 -263.9 -281.9 258.7  
Pre-tax profit without non-rec. items  -296 -95.4 -337 -361 259  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  -9,220 -9,289 -9,553 -9,835 259  
Interest-bearing liabilities  9,197 9,426 9,583 9,734 0.0  
Balance sheet total (assets)  258 340 268 389 408  

Net Debt  9,079 9,379 9,425 9,513 -117  
 
See the entire balance sheet

Volume 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  304 698 580 877 517  
Gross profit growth  9.6% 129.6% -16.9% 51.2% -41.0%  
Employees  1 1 1 1 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  258 340 268 389 408  
Balance sheet change%  371.7% 31.6% -21.0% 45.2% 4.9%  
Added value  -122.2 270.2 38.2 20.2 258.4  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -4.0 1.0 2.0 3.0 4.0  

Profitability 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  -40.2% 38.7% 6.6% 2.3% 50.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.7% 2.8% 0.4% 0.2% 4.9%  
ROI %  0.8% 2.9% 0.4% 0.2% 5.2%  
ROE %  52.7% -23.2% -86.8% -85.7% 79.8%  

Solidity 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Equity ratio %  -97.3% -96.5% -97.3% -96.2% 63.3%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -7,430.8% 3,471.2% 24,669.7% 47,112.8% -45.3%  
Gearing %  -99.8% -101.5% -100.3% -99.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  4.0% 3.9% 3.9% 3.9% 0.0%  

Liquidity 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Quick Ratio  0.9 1.7 1.1 0.8 2.6  
Current Ratio  0.9 1.7 1.1 0.8 2.6  
Cash and cash equivalent  118.4 46.8 157.7 221.4 116.9  

Capital use efficiency 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -22.2 137.0 17.5 -112.8 246.3  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Net sales / employee  0 0 0 0 0  
Added value / employee  -122 270 38 20 258  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  -122 270 38 20 258  
EBIT / employee  -122 270 38 20 258  
Net earnings / employee  82 -69 -264 -282 259